HealthcareServices

Hepatitis Diagnostic Tests Market Anticipated to Record Steady Gains, Advancing to $6.72 Billion by 2030

February 25, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the hepatitis diagnostic tests market from 2026–2035 with trusted insights from The Business Research Company

What are the forecasted starting (2026) and ending (2030) market sizes for the Hepatitis Diagnostic Tests Market?

The hepatitis diagnostic tests market size has exhibited strong growth over recent years. Its value is anticipated to rise from $4.93 billion in 2025 to $5.21 billion in 2026, at a compound annual growth rate (CAGR) of 5.7%. This expansion in the past can be attributed to the proliferation of hepatitis screening programs, higher volumes of laboratory testing, increased understanding of viral hepatitis, improved availability of diagnostic infrastructure, and the implementation of standardized testing protocols.

The hepatitis diagnostic tests market is anticipated to exhibit robust expansion over the next few years, with its size projected to reach $6.72 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.6%. This growth during the forecast period is primarily fueled by increasing demand for decentralized diagnostics, rising investments in advanced molecular testing, the expansion of home-based testing solutions, a growing emphasis on early disease detection, and increased adoption in low-resource settings. Significant trends expected during this period include the increasing adoption of rapid diagnostic tests, the rising utilization of molecular diagnostic technologies, greater integration of automated laboratory systems, the expansion of point-of-care testing solutions, and an enhanced focus on early and accurate diagnosis.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13153&type=smp

What Drivers Are Supporting Technological Adoption In The Hepatitis Diagnostic Tests Market?

The increasing volume of blood transfusions and donations is anticipated to fuel the expansion of the hepatitis diagnostic test market in the future. These processes are closely linked, involving individuals voluntarily providing blood that is then collected, screened, and later given to patients needing extra blood components for various medical conditions, or to compensate for blood loss from operations, accidents, or diseases. To guarantee patient safety, hepatitis diagnostic tests are employed for comprehensive screening of blood prior to both donation and transfusion. As an illustration, in August 2023, data from the Royal College of Pathologists, a UK-based organization, indicated that blood transfusion is the most frequently performed procedure for hospitalized patients, with nearly 2 million blood components distributed and transfused in England annually, costing over £300 ($390.69) million. Consequently, the growing frequency of blood transfusions and donations stimulates the hepatitis diagnostic test market.

Which Segments Are Contributing To The Growth Of The Hepatitis Diagnostic Tests Market?

The hepatitis diagnostic tests market covered in this report is segmented –

1) By Test Type: Blood Tests, Imaging Tests, Liver Biopsy

2) By Technology: Enzyme-Linked Immunosorbent Assay (ELISA), Rapid Diagnostic Tests (RDTs), Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Test (INAAT), Other Technologies

3) By End User: Hospitals, Diagnostic Laboratories, Blood Bank, Other End Users

Subsegments:

1) By Blood Tests: Serological Tests, Polymerase Chain Reaction (PCR) Tests, Enzyme-Linked Immunosorbent Assays (ELISA)

2) By Imaging Tests: Ultrasound, Computed Tomography (CT), Magnetic Resonance Imaging (MRI)

3) By Liver Biopsy: Percutaneous Biopsy, Transjugular Biopsy, Laparoscopic Biopsy

Which Trends Are Shaping Activity Within The Hepatitis Diagnostic Tests Market?

Leading companies in the hepatitis diagnostic test market are concentrating on developing innovative automated immunoassays, such as Elecsys HCV Duo, to deliver dependable customer service. Automated immunoassays, like Elecsys HCV Duo, are laboratory techniques that utilize automation systems and specialized instruments to perform all stages of the immunoassay procedure, including sample handling, reagent mixing, incubation, detection, and result calculation. For example, in July 2023, Roche Diagnostics India, an India-based biotechnology research company, introduced Elecsys HCV Duo. This product is India’s first commercially available fully automated immunoassay, allowing for simultaneous and independent measurement of hepatitis C virus (HCV) antigen and antibody levels from a single human plasma or serum sample. This also facilitates single specimen testing and streamlines the diagnostic algorithm, which reduces the number of visits needed for additional tests and can lessen the overall burden of testing on the healthcare system.

Who Are The Prominent Global Companies Shaping The Hepatitis Diagnostic Tests Market Landscape?

Major companies operating in the hepatitis diagnostic tests market are Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Roche Diagnostics, Quest Diagnostics Incorporated, Grifols S.A, Hologic Inc., BioMérieux SA, Beckman Coulter Inc., Bio-Rad Laboratories Inc., SD Biosensor Co. Ltd., QIAGEN N.V., DiaSorin S.p.A., Randox Laboratories Ltd., Luminex Corporation, Fujirebio Diagnostics Inc., Trivitron Healthcare Private Limited, Trinity Biotech plc, MP Biomedicals LLC, R-Biopharm AG, Creative Diagnostics, InBios International Inc., Dia.Pro Diagnostic Bioprobes srl, DIALAB GmbH

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/hepatitis-diagnostic-tests-global-market-report

Which Region Is Projected To Lead The Hepatitis Diagnostic Tests Market During The Forecast Period?

North America was the largest region in the hepatitis diagnostic tests market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hepatitis diagnostic tests market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Hepatitis Diagnostic Tests Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13153&type=smp

Browse Through More Reports Similar to the Global Hepatitis Diagnostic Tests Market 2026, By The Business Research Company

Viral Hepatitis Market Report 2026

https://www.thebusinessresearchcompany.com/report/viral-hepatitis-global-market-report

Liver Cancer Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/liver-cancer-diagnostics-global-market-report

Infectious Disease Diagnostics Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/infectious-disease-diagnostics-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795